TN-U.S.-COTTON-TRUST
13.6.2022 14:34:06 CEST | Business Wire | Press release
The U.S. Cotton Trust Protocol has been approved as a standard for sustainable cotton by Siegelklarheit , an initiative of the German Federal Government. By helping consumers to better understand environmental and social labels, Siegelklarheit wants to contribute to more sustainable purchasing decisions. U.S. Cotton Trust Protocol successfully passed Siegelklarheit ´s assessment system. As a result, members of the Partnership for Sustainable Textiles (PST) can use the Trust Protocol as another standard to calculate their share of sustainable cotton.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220613005297/en/
The Partnership for Sustainable Textiles was founded in October 2014, with the mission to improve social and ecological conditions within global textile supply chains. The Textiles Partnership orientates its work on the OECD Due Diligence Guidance and on international agreements and guidelines that define the principles of social, environmental, and economic sustainability and the framework for corporate responsibility.
“Members of the Partnership for Sustainable Textiles work together to achieve substantial social and ecological improvements in their global supply chains,” said Jürgen Janssen, head of the PST secretariat. “This also includes the production of raw materials and thus the cultivation and processing of cotton. In the Textiles Partnership, we advocate for transparent and traceable criteria in the certification of sustainable cotton. We are pleased that the Trust Protocol has successfully passed the audit by Siegelklarheit .”
The PST has developed an implementation framework and reporting format for corporate due diligence. In the context of this format PST member companies also indicate how much cotton they source and how much of it is sustainable or organic cotton, certified by recognized standards. Besides U.S. Cotton Trust Protocol, these include Better Cotton standard, the Australian myBMP standard, Cotton made in Africa, Fairtrade Cotton and CottonConnect. The following standards apply to purchasing of organic cotton: the Global Organic Textile Standard (GOTS), the International Association of Natural Textile Industry (NATURTEXTIL IVN) standard, the Textile Exchange Organic Content Standard (OCS), the bioRe Social & Environmental Standard, and all the organic standards forming part of the IFOAM Family of Standards.
The Trust Protocol is the only system that provides quantifiable, verifiable goals and measurement and drives continuous improvement in six key sustainability metrics - land use, soil carbon, water management, soil loss, greenhouse gas emissions, and energy efficiency. It is also the world’s first sustainable cotton fiber to offer its members article-level supply chain transparency through the Protocol Consumption Management Solution.
“We are thrilled to have received this recognition of being a sustainable cotton standard by the Partnership for Sustainable Textiles and proud to have passed Siegelklarheit’s rigorous assessment,” said Dr. Gary Adams, president of the U.S. Cotton Trust Protocol. “The Trust Protocol’s vision is to set a new standard in sustainable cotton production where full transparency is a reality and continuous improvement to reduce our environmental footprint is the central goal. We commit to ensuring the protection and preservation of the planet, using the most sustainable and responsible techniques.”
The U.S. Cotton Trust Protocol is aligned with the UN Sustainable Development Goals , recognized by Textile Exchange and Forum for the Future, and part of the Sustainable Apparel Coalition , Cotton 2025 Sustainable Cotton Challenge, Cotton 2040 and Cotton Up initiatives. It has also been recognized and published in the ITC Standards Map.
To learn more about the U.S. Cotton Trust Protocol visit TrustUSCotton.org .
About the U.S. Cotton Trust Protocol
Launched in 2020, the U.S. Cotton Trust Protocol was designed to set a new standard in more sustainably grown cotton, ensuring that it contributes to the protection and preservation of the planet, using the most sustainable and responsible techniques. It is the only farm level, science-based program that provides quantifiable, verifiable goals and measurement in six key sustainability metrics as well as article-level supply chain transparency.
The Trust Protocol is overseen by a multi-stakeholder Board of Directors comprised of representatives from brands and retailers, civil society, and independent sustainability experts as well as the cotton-growing industry, including growers, ginners, merchants, wholesalers and cooperatives, mills, and cottonseed handlers.
About the Partnership for Sustainable Textiles
The Partnership for Sustainable Textiles (PST) is committed to a socially, ecologically, and corruption-free textile and garment industry – an industry that respects the rights of all workers, that protects the climate and the environment, and operates with integrity and within planetary boundaries. The Textiles Partnership aligns its work on international agreements and guidelines that define the principles of social, environmental, and economic sustainability and set the framework for corporate responsibility. The objectives of the PST concerning social and human rights issues are based in particular on the ILO Conventions, the UN Principles on Business and Human Rights, and the OECD Guidelines for Multinational Enterprises. In implementing its goals, the Partnership is strongly oriented towards the recommendations of the OECD. In order to achieve its goals, the PST places a special focus on the implementation of corporate due diligence and responsible business conduct in Germany, Europe and worldwide.
Website: https://www.textilbuendnis.com/en
Visit us online at TrustUSCotton.org .
Follow us at:
https://twitter.com/trustuscotton
https://www.facebook.com/trustuscotton/
https://www.instagram.com/trustuscotton/
https://www.linkedin.com/company/responsibleuscotton/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220613005297/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
